The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses (Q42925757)

11 November 2017

The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses (English)

1 reference

11 November 2017

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6633347&resulttype=core&format=json

15 May 2020

Silvia Sorce

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6633347&resulttype=core&format=json

15 May 2020

Luigia Trabace

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6633347&resulttype=core&format=json

15 May 2020

author name string

Stefania Schiavone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6633347&resulttype=core&format=json

15 May 2020

Marilena Colaianna

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6633347&resulttype=core&format=json

15 May 2020

Vincent Jaquet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6633347&resulttype=core&format=json

15 May 2020

Vincenzo Cuomo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6633347&resulttype=core&format=json

15 May 2020

Michel Dubois-Dauphin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6633347&resulttype=core&format=json

15 May 2020

Karl-Heinz Krause

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6633347&resulttype=core&format=json

15 May 2020

language of work or name

English

0 references

publication date

1 August 2010

1 reference

11 November 2017

Journal of Neuroscience

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6633347&resulttype=core&format=json

15 May 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6633347&resulttype=core&format=json

15 May 2020

issue

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6633347&resulttype=core&format=json

15 May 2020

page(s)

11317-11325

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6633347&resulttype=core&format=json

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

15 May 2020

cites work

1 reference

12 December 2020

NMDA receptor hypofunction model of schizophrenia

1 reference

12 December 2020

Gene therapy for chronic granulomatous disease

1 reference

12 December 2020

Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine

1 reference

12 December 2020

Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications

1 reference

12 December 2020

Genetic animal models: focus on schizophrenia

1 reference

12 December 2020

Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter

1 reference

12 December 2020

Glutamatergic mechanisms in schizophrenia

1 reference

12 December 2020

Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics

1 reference

12 December 2020

Decreased hyperlocomotion induced by MK-801, but not amphetamine and caffeine in mice lacking cellular prion protein (PrP(C)).

1 reference

12 December 2020

Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs

1 reference

12 December 2020

Glutamate-dependent inhibition of dopamine release in striatum is mediated by a new diffusible messenger, H2O2.

1 reference

12 December 2020

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

1 reference

12 December 2020

Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions

1 reference

12 December 2020

The NMDA receptor hypofunction model of psychosis

1 reference

12 December 2020

Regulation of N-methyl-D-aspartate receptors by calpain in cortical neurons

1 reference

12 December 2020

Cortical inhibitory neurons and schizophrenia

1 reference

12 December 2020

Mechanisms of neurotransmitter release by amphetamines: a review

1 reference

12 December 2020

A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons.

1 reference

12 December 2020

Behavioral effects of ketamine and toxic interactions with psychostimulants

1 reference

12 December 2020

Dose-response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity.

1 reference

12 December 2020

Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in vivo microdialysis

1 reference

12 December 2020

Synaptic plasticity deficits and mild memory impairments in mouse models of chronic granulomatous disease

1 reference

12 December 2020

Nox2 Is Determinant for Ischemia-Induced Oxidative Stress and Arterial Vasodilatation: A Pilot Study in Patients With Hereditary Nox2 Deficiency

1 reference

12 December 2020

Sources and targets of reactive oxygen species in synaptic plasticity and memory

1 reference

12 December 2020

The essential oil of bergamot enhances the levels of amino acid neurotransmitters in the hippocampus of rat: implication of monoterpene hydrocarbons.

1 reference

12 December 2020

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

1 reference

12 December 2020

Excitotoxicity and focal cerebral ischemia induce truncation of the NR2A and NR2B subunits of the NMDA receptor and cleavage of the scaffolding protein PSD-95.

1 reference

12 December 2020

Soluble amyloid beta1-42 reduces dopamine levels in rat prefrontal cortex: relationship to nitric oxide.

1 reference

12 December 2020

Deficits in parvalbumin and calbindin immunoreactive cells in the hippocampus of isolation reared rats.

1 reference

12 December 2020

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

1 reference

12 December 2020

NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons

1 reference

12 December 2020

Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder

1 reference

12 December 2020

Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice

1 reference

12 December 2020

Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase

1 reference

12 December 2020

Novel drugs and therapeutic targets for severe mood disorders

1 reference

12 December 2020

The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects

1 reference

12 December 2020

Models of schizophrenia in humans and animals based on inhibition of NMDA receptors

1 reference

12 December 2020

Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase

1 reference

12 December 2020

The absence of 5-HT(1A) receptors has minor effects on dopamine but not serotonin release evoked by MK-801 in mice prefrontal cortex.

1 reference

12 December 2020

Transcriptional responses to intermittent hypoxia

1 reference

12 December 2020

The acute effects of NMDA antagonism: from the rodent to the human brain

1 reference

12 December 2020

Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticity

1 reference

12 December 2020

NMDA receptor subunit expression in GABAergic interneurons in the prefrontal cortex: application of laser microdissection technique

1 reference

12 December 2020

Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia

1 reference

12 December 2020

Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets

1 reference

12 December 2020

NOX enzymes in the central nervous system: from signaling to disease

1 reference

12 December 2020

Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats.

1 reference

12 December 2020

Emerging role of glutamate in the pathophysiology of major depressive disorder.

1 reference

12 December 2020

The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients

1 reference

12 December 2020

Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats.

1 reference

12 December 2020

Mitochondria are the source of hydrogen peroxide for dynamic brain-cell signaling

1 reference

12 December 2020

Isoprostenes as indicators of oxidative stress in schizophrenia.

1 reference

12 December 2020

Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study

1 reference

12 December 2020

Glutamate-based antidepressants: 20 years on.

1 reference

12 December 2020

Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes

1 reference

12 December 2020

Influence of benzodiazepine tranquilizers on amphetamine-induced locomotor stimulation in mice

1 reference

12 December 2020

The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias

1 reference

12 December 2020

The disruptive effects of ketamine on passive avoidance learning in mice: involvement of dopaminergic mechanism.

1 reference

12 December 2020

Differential influence of associative and nonassociative learning mechanisms on the responsiveness of prefrontal and accumbal dopamine transmission to food stimuli in rats fed ad libitum.

1 reference

12 December 2020

Elevated plasma lipid peroxides at the onset of nonaffective psychosis

1 reference

12 December 2020

Inhibition by diazepam of ketamine-induced hyperlocomotion and dopamine turnover in mice.

1 reference

12 December 2020

10.1523/JNEUROSCI.1491-10.2010

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6633347&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6633347&resulttype=core&format=json

15 May 2020

1 reference